Towards Healthcare
Disposable Endoscopes Market to Rise at 16.59% CAGR till 2034

Disposable Endoscopes Market Boosted by Hospitals and Specialty Clinics

According to market projections, the global disposable endoscopes market, valued at USD 2.38 billion in 2024, is anticipated to reach USD 11.07 billion by 2034, growing at a CAGR of 16.59% over the next decade. The disposable endoscopes market is growing as it is increasing applications in gastrointestinal (GI) endoscopy, urology, gynecology, and pulmonology. It supports a streamlined workflow. Offers reliably high quality and performance. North America is the dominant market due to the high prevalence of gastrointestinal disorders and the increasing demand for less invasive care.

Category: Medical Devices Insight Code: 6198 Format: PDF / PPT / Excel

The global disposable endoscopes market size is estimated at US$ 2.38 billion in 2024, is projected to grow to US$ 2.77 billion in 2025, and is expected to reach around US$ 11.07 billion by 2034. The market is projected to expand at a CAGR of 16.59% between 2025 and 2034.

Disposable Endoscopes Market Size 2024 to 2034

The disposable endoscopes market is growing due to advancements in technology, the growing need for infection control, and cost-effective solutions. Medical care professionals are shifting towards the disposable endoscope due to its lower cross-contamination challenges and elimination of processing expenses. North America is dominant in the market due to increasing government support and spending in healthcare, while the Asia Pacific is the fastest growing in the market due to increasing disposable incomes and increasing chronic diseases.

Key Takeaways

  • The disposable endoscopes market will likely exceed USD 2.38 billion by 2024.
  • Valuation is projected to hit USD 11.07 billion by 2034.
  • Estimated to grow at a CAGR of 16.59% starting from 2025 to 2034.
  • By region, North America was dominant in the disposable endoscopes market in 2024, with approximately 40% share.
  • By region, Asia Pacific is estimated to grow at the fastest CAGR from 2025 to 2034.
  • By product type, the gastroscopes segment is dominant in 2024, with approximately 28% share.
  • By product type, the others segment is estimated to be the fastest-growing over the forecast period, 2025 to 2034.
  • By end user, the hospitals segment is dominant in the market in 2024, with approximately 60% share.
  • By end user, the specialty clinics segment is expected to register the fastest growth over the forecast period, 2025 to 2034.
  • By procedure type, the diagnostic procedures segment is dominant in the disposable endoscopes market in 2024.
  • By procedure type, the therapeutic procedures segment is expected to register the fastest growth over the forecast period, 2025 to 2034.

Quick Facts Table

Table Scope
Market Size in 2025 USD 2.77 Billion
Projected Market Size in 2034 USD 11.07 Billion
CAGR (2025 - 2034) 16.59%
Leading Region North America by 40%
Market Segmentation By Product Type, By End User, By Procedure Type, By Region
Top Key Players Ambu A/S, Boston Scientific Corporation, Medtronic plc, Pentax Medical (Hoya Corporation), Fujifilm Holdings Corporation, CONMED Corporation, KARL STORZ SE & Co. KG, Smith & Nephew plc, Cook Medical, ERBE Elektromedizin GmbH, Halyard Health (now part of Owens & Minor), Merit Medical Systems, Inc., EndoChoice, Inc., Vision Sciences, Inc., Micro-Tech (Nanjing) Co., Ltd., Steris plc, Zhejiang Kangli Medical Instrument Co., Ltd., Shandong Weigao Group, Hangzhou Edge Medical Technology, Guangdong Landwind Medical Instrument Co., Ltd.

What are the Disposable Endoscopes?

The disposable endoscopes market refers to single-use endoscopic devices designed for minimally invasive procedures across gastroenterology, pulmonology, urology, ENT, and other surgical applications. Unlike reusable endoscopes, disposable endoscopes eliminate cross-contamination risks, reduce hospital reprocessing costs, and enhance workflow efficiency. Market growth is driven by infection control concerns, rising surgical procedures, technological advancements in imaging, and increasing adoption in hospitals and outpatient centers.

Increasing government support for the medical device manufacturing and adoption of novel technology, which contributes to the growth of the market.

For instance,

  • In May 2025, Olympus, a global medical technology company committed to making people’s lives healthier, safer, and more fulfilling, announced FDA 510(k) clearance of its EZ1500 series endoscopes featuring Extended Depth of Field (EDOF) technology. EDOF endoscopes, the GIF-EZ1500 gastroscope, and the CF-EZ1500DL/I colonoscope – represent Olympus’ most advanced imaging and latest innovation as part of the EVIS X1™ endoscopy system

Increasing collaboration between the government organization and healthcare companies, which drives the growth of the market.

For Instance,

  • In July 2025, FUJIFILM Ltd. continues to advance healthcare diagnostics and patient treatment with comprehensive health innovations, unveiling the ELUXEO 8000 Endoscopy System and the 800 Series ELUXE Endoscopes for the first time in Thailand. The launch took place at the 50th Annual Scientific Congress of the Royal College of Surgeons of Thailand, organized in collaboration with the Ministry of Public Health and the National Health Security Office under the theme "RCST Half Century: The Changing Landscape of Surgery."

What is the Role of AI in the Growth of the Disposable Endoscopes Market?

Integration of AI in disposable endoscopes drives the growth of the market as AI allows real-time visual feedback throughout endoscopic measures, significantly increasing the precision and safety of medicine administration. AI-driven endoscopy has the strength to enhance both patient results and instantaneously lower physician workload. These AI-powered systems analyse huge amounts of endoscopic imagery, offering immediate feedback to clinicians and highlighting areas of concern that the human eye might overlook.

AI is transforming the landscape of endoscopic technology by improving diagnostic precision and growing the efficiency of medical care services. AI-based endoscopy has immense promise in transforming healthcare diagnostics and enhancing patient outcomes. AI-driven technology can offer real-time data analysis and prognostic insights, which is attractive for diagnostic precision and management of resources.

Market Dynamics

Driver

Growing Interest in Disposable Endoscopes

Increasing interest in single-use, disposable endoscopes has increased due to worries about infection risks with reusable types. It is suggested that switching to sterilization methods or adopting sterile, disposable endoscopes is vital for patient safety. These single-use devices could reduce downtime and enhance safety during procedures. They also eliminate reprocessing, associated costs, staffing needs, and training requirements. An early study comparing a disposable sheath for fiber optic sigmoidoscopy with traditional reprocessing highlighted the market potential for disposable endoscopes.

Restraint

Major Challenges in the Disposable Endoscope

Several factors influence reprocessing effectiveness, such as non-adherence to guidelines, using damaged endoscopes, employing insoluble products during endoscopy, insufficient cleaning, contaminated rinse water, and inadequate drying before storage. These issues hinder the growth of the disposable endoscope market.

Opportunity

Increasing Advancement in Endoscopy Technology

Endoscopy is a groundbreaking medical technique that has revolutionized how healthcare professionals investigate and treat various conditions. Its minimally invasive approach is crucial in modern diagnostics, allowing physicians to examine the gastrointestinal tract and other internal organs without resorting to traditional surgery. Endoscopy has become a vital component of medical practice across multiple specialties, including gastroenterology, pulmonology, and urology.

It has proven to be a reliable and effective diagnostic method, leading to better patient outcomes. These technological improvements have significantly expanded endoscopy's role in diagnosing and managing numerous medical issues, making it an increasingly essential tool in medicine and opening opportunities for the disposable endoscopes market. 

Segmental Insights

Why the Gastroscopes Segment Dominated the Market?

By product type, the gastroscopes segment led the disposable endoscopes market, as gastroscopy supports the diagnosis of different conditions, including gastroesophageal reflux disease (GERD) and duodenal ulcers. Doctors use gastroscopy to look at the stomach from the front and side and make a diagnosis. Endoscopy is relatively harmless, fast, and easy. It is an efficient way to ensure that there are no serious illnesses.

On the other hand, the others segment is projected to experience the fastest CAGR from 2025 to 2034, as endoscope offers light and magnification, and they allow measures to be performed in the ears with lower pain and less potential for injury. ENT endoscopy is shown as an advanced solution for more precise diagnosis and treatment of various ENT challenges. Laparoscopic surgery allows physicians to see inside the body without making large cuts, leading to quicker times.

Why the Hospitals Segment Dominated the Market?

By end user, the hospitals segment is dominant in the disposable endoscopes market in 2024, as disposable endoscope solutions in hospitals remove expenses related to reusable endoscopes and provide several advantages, including a relatively lower capital investment and the elimination of endoscope reprocessing, service, and repair expenses. Healthcare physicians find disposable endoscopes suitable because they are simple to dispose of. They don’t require superior handling or disposal processes; therefore, they are disposed of in regular trash. This saves time and resources for healthcare professionals.

The specialty clinics segment is projected to grow at the fastest CAGR from 2025 to 2034, as these clinics specialize in diseases of the digestive system and use an endoscopy to diagnose and manage diseases that affect the upper part of the digestive system. Endoscopy Clinic performs a broad range of endoscopic processes, which allow both treatment and diagnosis of gastrointestinal disorders, like cancers, polyps, peptic ulcers, and blockages of the bile ducts, including stones, inflammation, and tumors.

Why is the Diagnostic Procedures Segment Dominant in the Market?

By procedure type, the diagnostic procedures segment led the disposable endoscopes market in 2024, as endoscopy is used to identify cancer, inflammation, celiac disease, obstructions, bleeding, ulcers, and ulcerations. An analytical endoscopy is an inspection of internal organs using an instrument such as an endoscope. It allows physicians to diagnose, examine, and treat situations without the requirement for complicated surgery.

The therapeutic procedures segment is projected to experience the fastest CAGR from 2025 to 2034 as these procedures offer important advantages by allowing a broad range of therapies, like eliminating polyps, regulating bleeding, and widening narrow areas. The procedure of endoscopy is challenge-free. It has a low risk and is regarded as one of the harmless medical therapeutics.

Regional Insights

Disposable Endoscopes Market Share, By Region, 2024 (%)

Why is North America dominant in the Disposable Endoscopes Market?

North America is dominant in the market share by 40% in 2024, due to the presence of advanced healthcare infrastructure, increasing spending on modern medical devices, and increasing healthcare awareness are the major drivers of the market. The increasing prevalence of chronic diseases and the huge presence of disposable endoscopes manufacturing companies such as Ambu, Olympus, Karl Storz, Boston Scientific, and Pentax contribute to the growth of the market.

For Instance,

  • In June 2025, Ambu announced that the US Food and Drug Administration (FDA) had granted expanded 510(k) clearance for the Ambu aScope 5 Cysto HD, authorising the endoscope’s use in percutaneous nephrolithotomy (PCNL) procedures. It is a procedure performed in the operating room to remove large or complex kidney stones by creating a small passageway through the patient’s back to the kidney.

U.S. Disposable Endoscopes Market Trends

In the United States, there is an increasing focus on infection control, which is increasing the demand for disposable endoscopes due to increasing infectious outbreaks. The U.S. government provides a higher budget for the manufacturing of healthcare devices, which contributes to the growth of the market.

Canada Disposable Endoscopes Market Trends

Canada's medical devices industry is highly diversified, and there is a greater adoption of durable medical equipment. Technological advancements such as robotic surgery and mobile health, combined with government spending, drive the growth of the market.

Why is Asia Pacific the Fastest Growing in Market?

Asia Pacific is the fastest-growing region in the disposable endoscopes market in the forecast period, due to increasing urbanization and increasing awareness regarding infection control. The increasing prevalence of chronic diseases such as cancer, cardiovascular disease, and renal disease increases the demand for disposable endoscopes. Cost efficacy of disposable products reduces costs related to reprocessing, cleaning, and sterilization, which contributes to the growth of the market.

Disposable Endoscopes Market – Value Chain Analysis

R&D

Manufacturers are investing heavily in R&D to enhance usability and performance. R&D processes include pre-cleaning, leak testing, manual cleaning, visual inspection, storage, and documentation.

Key Players:  Olympus and Boston Scientific

Clinical Trials

The pilot trial is to demonstrate the efficacy, feasibility, safety, and clinical outcomes of third-space endoscopic procedures completed using a disposable endoscope platform.

Key Players:  Ambu A/S, and Karl Storz

Patient Support and Services

Disposable endoscopes lower the challenges of post-procedure infection caused by cross-contamination. Health care providers working in different specialties, including gastroenterology, otolaryngology, gynecology, and orthopaedics.

Key Players: Hoya and Medtronic

Top Companies in the Disposable Endoscopes Market

Disposable Endoscopes Market Companies

  • Ambu A/S
  • Boston Scientific Corporation
  • Medtronic plc
  • Pentax Medical (Hoya Corporation)
  • Fujifilm Holdings Corporation
  • CONMED Corporation
  • KARL STORZ SE & Co. KG
  • Smith & Nephew plc
  • Cook Medical
  • ERBE Elektromedizin GmbH
  • Halyard Health (now part of Owens & Minor)
  • Merit Medical Systems, Inc.
  • EndoChoice, Inc.
  • Vision Sciences, Inc.
  • Micro-Tech (Nanjing) Co., Ltd.
  • Steris plc
  • Zhejiang Kangli Medical Instrument Co., Ltd.
  • Shandong Weigao Group
  • Hangzhou Edge Medical Technology
  • Guangdong Landwind Medical Instrument Co., Ltd.

Latest Announcements by Industry Leaders

In August 2025, Graham Reeve, Chief Operating Officer-West, stated, “As a leading global MedTech company, Olympus remains committed to providing advanced options to help physicians offer their patients the best care possible. Our goal is to elevate the standard of endoscopy, and Extended Depth of Field (EDOF) technology represents Olympus’ most advanced scope technology to help physicians drive the best clinical outcomes for advancing gastrointestinal procedures.”

Recent Developments in the Disposable Endoscopes Market

  • In July 2025, Pristine Surgical, the leading maker of single-use, digital arthroscopes, announced the appointment of Susan O’Shea to Chief Financial Officer. A proven medtech executive with more than two decades of financial leadership in regulated, high-growth environments, Susan will lead Pristine’s financial strategy, capital formation, and operational infrastructure as the company accelerates commercial growth.
  • In September 2025, Olympus Corp., a global medical technology company committed to making people’s lives healthier, safer, and more fulfilling, announced an exclusive global distribution agreement with MacroLux Medical Technology Co., Ltd. to distribute single-use urology products.

Segments Covered in the Report

By Product Type

  • Gastroscopes
  • Bronchoscopes
  • Ureteroscopes
  • Cystoscopes
  • Colonoscope
  • Others (ENT scopes, laparoscopes)

By End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty Clinics

By Procedure Type

  • Diagnostic Procedures
  • Therapeutic Procedures

By Region 

  • North America
    • U.S.
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Thailand
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait

List of Figures

  • Global Disposable Endoscopes Market Size, 2024–2034 (USD Billion)
  • Global Disposable Endoscopes Market CAGR Forecast, 2025–2034 (16.59%)
  • Regional Market Share, 2024 – North America (40%), Europe (25%), Asia Pacific (22%), Latin America (7%), MEA (6%)
  • Regional CAGR Forecast, 2025–2034 – North America (14%), Europe (15%), Asia Pacific (19%), Latin America (16%), MEA (13%)
  • Product Type Share, 2024 – Gastroscopes (28%), Bronchoscopes (20%), Ureteroscopes (12%), Cystoscopes (10%), Colonoscopes (15%), Others (15%)
  • End User Share, 2024 – Hospitals (60%), Ambulatory Surgery Centers (25%), Specialty Clinics (15%)
  • Procedure Type Share, 2024 – Diagnostic (70%), Therapeutic (30%)
  • AI Integration in Disposable Endoscopes – Real-time feedback and improved diagnostic precision
  • Competitive Landscape – Market presence of Ambu, Boston Scientific, Olympus, Medtronic, Fujifilm, Karl Storz, and others
  • Regional Insights – U.S. infection control focus, Canada diversified medtech, Asia Pacific fast adoption

List of Tables

  • Quick Facts – Market Size 2025 (USD 2.77 Bn), Market Size 2034 (USD 11.07 Bn), CAGR 16.59%, Leading Region North America (40%)
  • Product Type Segmentation, 2024 – Gastroscopes (28%), Bronchoscopes (20%), Ureteroscopes (12%), Cystoscopes (10%), Colonoscopes (15%), Others (15%)
  • End User Segmentation, 2024 – Hospitals (60%), Ambulatory Surgery Centers (25%), Specialty Clinics (15%)
  • Procedure Type Segmentation, 2024 – Diagnostic (70%), Therapeutic (30%)
  • Regional Market Share, 2024 – North America (40%), Europe (25%), Asia Pacific (22%), Latin America (7%), MEA (6%)
  • Regional CAGR Forecast, 2025–2034 – North America (14%), Europe (15%), Asia Pacific (19%), Latin America (16%), MEA (13%)
  • Value Chain Analysis – R&D, Clinical Trials, Patient Support & Services
  • Key Players – Ambu A/S, Boston Scientific, Medtronic, Olympus, Fujifilm, Karl Storz, Smith & Nephew, and others
  • Recent Developments – Olympus EDOF launch, Fujifilm ELUXEO system, Ambu aScope 5 Cysto clearance, Pristine Surgical leadership update
  • Regional Insights – U.S. strong FDA support, Canada tech adoption, Asia Pacific rising chronic diseases, Europe medtech innovation, MEA gradual uptake

Tags

  • Last Updated: 23 September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi plays a critical role in ensuring the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar

Related Reports

FAQ's

The disposable endoscopes market stands at USD 2.77 billion in 2025 and is expected to reach USD 11.07 billion by 2034, growing at a CAGR of 16.59% from 2024 to 2034.

North America is currently leading the disposable endoscopes market share by 40% due to high adoption of innovative technologies and high prevalence of chronic diseases.

The disposable endoscopes market includes three segments by product type, by end-user, by procedure type, and by region.

Some key players include Ambu A/S, Boston Scientific Corporation, Medtronic plc, Pentax Medical (Hoya Corporation), Fujifilm Holdings Corporation, and CONMED Corporation.

Simple sponge-on-a-string test replaces the need for endoscopy for thousands of NHS patients. An innovative test trialled by the NHS to help diagnose a condition which can lead to oesophageal cancer has reduced the need for invasive endoscopy in thousands of low-risk patients.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.